Amplyx Pharmaceuticals Company
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Technology:
Metabolic Disorders
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2006
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership